Pfizer (PFE) May Seek to Sell Non-Prescription Lipitor
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Join SI Premium – FREE
Pfizer (NYSE: PFE) may seek to sell non-prescription, or OTC, Lipitor, according to sources. Shares turned up into the close on the report.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer (PFE) PT Lowered to $29 at Bernstein SocGen Group
- Definium's LSD-based pill meets Phase 3 goals in anxiety disorder trial
- North Shore Uranium finishes Phase 1 drilling at New Mexico project
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
